Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KalVista Pharmaceuticals (KALV) Non-Current Deffered Revenue (2016 - 2020)

Historic Non-Current Deffered Revenue for KalVista Pharmaceuticals (KALV) over the last 6 years, with Q1 2020 value amounting to $2.5 million.

  • KalVista Pharmaceuticals' Non-Current Deffered Revenue fell 3180.58% to $2.5 million in Q1 2020 from the same period last year, while for Jan 2020 it was $2.5 million, marking a year-over-year decrease of 3180.58%. This contributed to the annual value of $3.3 million for FY2019, which is 6923.22% down from last year.
  • KalVista Pharmaceuticals' Non-Current Deffered Revenue amounted to $2.5 million in Q1 2020, which was down 3180.58% from $2.8 million recorded in Q4 2019.
  • KalVista Pharmaceuticals' Non-Current Deffered Revenue's 5-year high stood at $13.9 million during Q1 2018, with a 5-year trough of $49000.0 in Q1 2016.
  • In the last 4 years, KalVista Pharmaceuticals' Non-Current Deffered Revenue had a median value of $3.5 million in 2019 and averaged $5.3 million.
  • Its Non-Current Deffered Revenue has fluctuated over the past 5 years, first crashed by 7360.5% in 2019, then tumbled by 3180.58% in 2020.
  • KalVista Pharmaceuticals' Non-Current Deffered Revenue (Quarter) stood at $49000.0 in 2016, then skyrocketed by 9430.61% to $4.7 million in 2018, then plummeted by 41.03% to $2.8 million in 2019, then decreased by 9.22% to $2.5 million in 2020.
  • Its last three reported values are $2.5 million in Q1 2020, $2.8 million for Q4 2019, and $2.9 million during Q3 2019.